Total planned funding: $1,215,758,759
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Nigeria | $293,510,442 |
| Uganda | $154,269,221 |
| Zambia | $141,254,379 |
| Kenya | $137,779,718 |
| Tanzania | $72,009,791 |
| Mozambique | $71,581,379 |
| South Africa | $54,502,862 |
| Ethiopia | $49,465,650 |
| Côte d'Ivoire | $42,474,661 |
| Rwanda | $39,245,614 |
| Haiti | $27,942,198 |
| Democratic Republic of the Congo | $25,151,182 |
| Vietnam | $21,814,128 |
| Zimbabwe | $20,842,664 |
| Cameroon | $15,618,594 |
| Botswana | $13,777,043 |
| Namibia | $7,936,239 |
| West Africa Region | $6,279,450 |
| Western Hemisphere Region | $4,359,019 |
| Asia Regional Program | $3,771,910 |
| Guyana | $3,377,832 |
| Eswatini | $2,592,471 |
| enumerations.Philippines | $2,522,418 |
| Burundi | $1,695,814 |
| Ukraine | $1,000,000 |
| Malawi | $414,365 |
| Lesotho | $300,000 |
| South Sudan | $146,238 |
| China | $100,000 |
| India | $23,477 |
Organizational Types
| Private Contractor | $857,202,726 |
| NGO | $128,521,264 |
| FBO | $71,453,240 |
| Unknown | $49,514,281 |
| University | $49,376,888 |
| Host Country Government Agency | $43,063,953 |
| Implementing Agency | $8,100,000 |
| Own Agency | $7,108,269 |
| Parastatal | $1,020,000 |
| Other USG Agency | $393,138 |
| Multi-lateral Agency | $5,000 |
Program Areas
| Treatment | $1,215,758,759 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $1,215,758,759 |
Top Partner Programs
Chemonics International:
$403,034,399
View countries
Medical Access Uganda Limited:
$60,105,826
View countries